The fellow to the right is Jeff Novitzky, the controversial federal agent who in 2004 led the raid on a drug lab that the 9th Circuit Court of Appeals has ruled violated the constitutional rights of the baseball players who took drug tests during the 2003 steroid survey. That ruling came after a previous, smaller panel of the same court weighed in. Which itself came a couple of years after the trial court weighed in. In other words, this thing has been dragging on forever.
Forever is about to get longer, though, because now the court is asking Players Association and the government whether an even larger, damn nigh unprecedented panel of appeals court judges should weigh in on the issue. The the court things that all 27 — yes, 27 — judges should hear the case, the thing could drag on for another two years. And that’s before the U.S. Supreme Court gets a chance to weigh in.
From a legal perspective it blows my mind that the court is so uncomfortable with its ruling — a ruling that says that the government can’t waltz into your doctor’s office with a search warrant for a specific patient’s records and walk out with the medical records of you and and your kids and your aunt Tilly and everyone. This seems pretty basic to me, but to the extent I’m wrong and it’s not basic, it’s something that the U.S. Supreme Court is going to have to rule on anyway, so why not get it to them sooner rather than later?
From a steroids-in-baseball perspective we stand in the same place we have stood for many years now: the court order sealing those test results remains in place, Mr. Novitzky’s seizure of the 2003 testing records currently stands as a violation the constitutional rights of players who took those drug tests, and anyone who leaks information relating to those 2003 test results is in criminal contempt of a federal court order.
But don’t let that stop Mr. Novitzky from continuing to be promoted rather than disciplined and the ignorant from demanding that the names from the famous list Novtizky created be released all the same.
Mariners’ right-hander Arquimedes Caminero is nearing a deal with the Yomiuri Giants of Nippon Professional Baseball, according to Bob Dutton of the Tacoma News Tribune. The club has reportedly agreed to sell the 29-year-old’s contract, Dutton writes, though no official move has been announced by either team yet. Caminero is under club control through 2020 and currently ineligible for arbitration.
The right-hander began the 2016 season with the Pirates but was sent to the Mariners in a trade for Seattle minor leaguers Jake Brentz and Pedro Vasquez in order to clear space in the Bucs’ bullpen. With the Mariners, Caminero produced a 3.66 ERA and 8.2 K/9 through 19 2/3 innings in the second half of the year. Although he boasts an electric fastball, one which consistently averaged 98.7 m.p.h. in 2016, his success rate has been tempered by poor control throughout his major league career. According to Dutton, the Mariners’ willingness to sell Caminero’s contract was a strong indication that they did not see him as a viable contender for their 2017 bullpen or as a potential trade chip further down the line.
Should the deal go through, the right-hander will be the second former Mariner to sign with a Japanese club for the 2017 season. Per Dutton’s report, outfielder Stefen Romero also picked up a contract with the Orix Buffaloes of NPB in late November.
During the Pirates’ FanFest on Saturday, right-hander Gerrit Cole announced that he is back up to full health after being shut down with elbow inflammation in September. Per Rob Biertempfel of the Pittsburgh Tribune-Review, Cole said he’ll start a throwing program on Monday as he works on regaining his form for the 2017 season.
The 26-year-old pitched through 116 innings for the Pirates in 2016, delivering a 3.88 ERA and 2.5 WARP before landing on the disabled list in June with a triceps strain and again in August with elbow inflammation. It was a steep drop for the right-hander, who saw a considerable spike in his ERA and BB/9 rate and struggled to strike out batters at the 8.7 mark he managed in 2015.
The upside? Inflammation was the worst of Cole’s issues in 2016, and while the newfound health issues didn’t help his case for an extension, a more serious injury doesn’t appear to be on the horizon.